Ronak Pharma Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 18-07-2024
- Paid Up Capital ₹ 0.50 M
as on 18-07-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2021)
- Profit 2.98%
(FY 2021)
- Ebitda 10.88%
(FY 2021)
- Net Worth -0.80%
(FY 2021)
- Total Assets -1.34%
(FY 2021)
About Ronak Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Samir Shah, Ramesh Jain, and Kishan Meena serve as directors at the Company.
- CIN/LLPIN
U52310MH2003PTC139263
- Company No.
139263
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Feb 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ronak Pharma?
Board Members(3)
Financial Performance and Corporate Structure Insights of Ronak Pharma.
Ronak Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 2.98% increase in profit. The company's net worth dipped by a decrease of 0.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ronak Pharma?
In 2017, Ronak Pharma had a promoter holding of 13.32% and a public holding of 86.68%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ronak Pharma?
Unlock and access historical data on people associated with Ronak Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ronak Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ronak Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
